Global trend and predictors of non-labelled sacubitril-valsartan dosing: results from IKNOW-HF survey. [PDF]
Yaseen IF +15 more
europepmc +1 more source
Fulfilling the Promise of Cyclic GMP Signaling in Heart Failure With Reduced Ejection Fraction. [PDF]
Reddy YNV.
europepmc +1 more source
Angiotensin receptor-neprilysin inhibitors improve the outcome of lung cancer patients with hypertension undergoing immune checkpoint inhibitors treatment. [PDF]
Shang C +7 more
europepmc +1 more source
Investigating the binding potential of the Melissa officinalis oil against Alzheimer's targets by molecular docking and in vitro evaluations. [PDF]
Kolouei A, Barati M, Abbas-Mohammadi M.
europepmc +1 more source
Effect of sacubitril/valsartan and SGLT2 inhibitors on arrhythmia burden in ICD patients. [PDF]
Öztürk F, Yaman M.
europepmc +1 more source
Clinical and Therapeutic Phenotypic Clustering and Prognostic Stratification in Heart Failure Patients With Atrial Fibrillation. [PDF]
Yano M +14 more
europepmc +1 more source
Pediatric Heart Failure Pharmacotherapy: Transformative Insights for the Future. [PDF]
Das BB.
europepmc +1 more source
Sacubitril/valsartan as a modulator of pulmonary fibrosis: insights into Lnc-SNHG-16/miR-455 modulation and Notch/Smad-3 pathway inhibition. [PDF]
Abdel-Nasser ZM, Zaafan MA.
europepmc +1 more source
Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNis) in High-Output Heart Failure in a Young Hemodialysis Patient: Synergistic or Cumulative Effect? [PDF]
Silva SR +4 more
europepmc +1 more source

